To investigate the clinical effect of detrusor botulinum toxin A (BoNT-A) injection on neurogenic detrusor overactivity (NDO) and renal function and to compare the difference of expressions of sensory receptors and nerve growth factor (NGF) in the bladder wall of patients respond and not respond to BoNT-A injections in chronic spinal cord injured (SCI) patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Net Change of the Urinary Distress Inventory (UDI-6)
Timeframe: Baseline and 12 months
Net Change of the Incontinence Impact Questionnaire (IIQ-7)
Timeframe: Baseline and 12 months
Net Change of the Quality of Life Index (QoL-I)
Timeframe: Baseline and 12 months